Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Psychiatry ; 20(10): 1161-72, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26260494

ABSTRACT

Alterations in glutamatergic transmission onto developing GABAergic systems, in particular onto parvalbumin-positive (Pv(+)) fast-spiking interneurons, have been proposed as underlying causes of several neurodevelopmental disorders, including schizophrenia and autism. Excitatory glutamatergic transmission, through ionotropic and metabotropic glutamate receptors, is necessary for the correct postnatal development of the Pv(+) GABAergic network. We generated mutant mice in which the metabotropic glutamate receptor 5 (mGluR5) was specifically ablated from Pv(+) interneurons postnatally, and investigated the consequences of such a manipulation at the cellular, network and systems levels. Deletion of mGluR5 from Pv(+) interneurons resulted in reduced numbers of Pv(+) neurons and decreased inhibitory currents, as well as alterations in event-related potentials and brain oscillatory activity. These cellular and sensory changes translated into domain-specific memory deficits and increased compulsive-like behaviors, abnormal sensorimotor gating and altered responsiveness to stimulant agents. Our findings suggest a fundamental role for mGluR5 in the development of Pv(+) neurons and show that alterations in this system can produce broad-spectrum alterations in brain network activity and behavior that are relevant to neurodevelopmental disorders.


Subject(s)
Interneurons/metabolism , Interneurons/pathology , Neurodevelopmental Disorders/metabolism , Neurodevelopmental Disorders/pathology , Parvalbumins/metabolism , Receptors, Kainic Acid/metabolism , Receptors, Metabotropic Glutamate/metabolism , Animals , Disease Models, Animal , Female , GABAergic Neurons/metabolism , GABAergic Neurons/pathology , Male , Mice , Mice, Knockout , Receptors, Metabotropic Glutamate/genetics
2.
Tissue Antigens ; 84(3): 308-15, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24957665

ABSTRACT

We analyzed the possible association between human leukocyte antigen-G (HLA-G) genetic variants, supposed to regulate HLA-G expression, and the susceptibility to develop rheumatoid arthritis (RA) as well as its clinical manifestations. The 5'upstream regulatory region (5'URR) and 3'untranslated region (3'UTR) regions of the HLA-G gene were screened in 127 RA patients and 128 controls: 10 5'URR and 3 3'UTR HLA-G polymorphisms as well as two haplotypes were associated with risk for RA development, while a polymorphism in the 5'URR showed an association with the degree of disease activity. These findings, although the number of cases analyzed is limited and the P-values are modest, indicate a possible association between HLA-G gene polymorphisms and susceptibility to develop RA disease and its severity.


Subject(s)
Arthritis, Rheumatoid/genetics , Arthritis, Rheumatoid/immunology , HLA-G Antigens/genetics , 3' Untranslated Regions/genetics , 5' Flanking Region/genetics , Aged , Brazil , DNA Mutational Analysis , Disease Progression , Female , Gene Frequency , Genetic Association Studies , Genetic Predisposition to Disease , Genotype , Haplotypes , Humans , Male , Middle Aged , Polymorphism, Single Nucleotide , Risk
3.
Neuropsychopharmacology ; 33(9): 2237-50, 2008 Aug.
Article in English | MEDLINE | ID: mdl-17987062

ABSTRACT

The immunological response in the brain is crucial to overcome neuropathological events. Some inflammatory mediators, such as the immunoregulatory cytokine interleukin-6 (IL-6) affect neuromodulation and may also play protective roles against various noxious conditions. However, the fundamental mechanisms underlying the long-term effects of IL-6 in the brain remain unclear. We now report that IL-6 increases the expression and function of the neuronal adenosine A1 receptor, with relevant consequences to synaptic transmission and neuroprotection. IL-6-induced amplification of A1 receptor function enhances the responses to readily released adenosine during hypoxia, enables neuronal rescue from glutamate-induced death, and protects animals from chemically induced convulsing seizures. Taken together, these results suggest that IL-6 minimizes the consequences of excitotoxic episodes on brain function through the enhancement of endogenous adenosinergic signaling.


Subject(s)
Interleukin-6/pharmacology , Neurons/drug effects , Receptor, Adenosine A1/metabolism , Synaptic Transmission/drug effects , Up-Regulation/drug effects , Analysis of Variance , Animals , Autoradiography/methods , Cell Survival/drug effects , Cells, Cultured , Cerebral Cortex/cytology , Embryo, Mammalian , Enzyme Inhibitors/pharmacology , Excitatory Amino Acid Agents/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/radiation effects , Hippocampus/drug effects , Hippocampus/physiology , Interleukin-6/deficiency , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Pentylenetetrazole/pharmacology , Radioligand Assay/methods , Receptor, Adenosine A1/genetics , Seizures/chemically induced , Seizures/drug therapy , Seizures/genetics , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...